GT Biopharma, Inc. (GTBP) AI Dilution Summary

Estimated cash was $9,245,365 as of 2026-10-01, from $4,960,000 at 2026-06-30 against estimated monthly burn of $1,121,333. The latest raise was $7,750,000 net in a Series M convertible preferred and warrants private placement on 2026-09-18, beside a $20,000,000 committed equity facility with Five Narrow Lane and Hailstone Peak.